MSB

7.64%

$1.48 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-30

First 30 Last

Share
Profile

Follow
tubbyguts

3,379 Posts.

285

02/10/20

13:01

Post #: 47808286
Share

Originally posted by Tiggietrain1719: ↑

My confusion about this meeting is that all of the evidence that MSB have, has already been presented, voted on with an overwhelming majority by ODAC and still knocked back. What more can they present or do to overturn it?

Expand

Another trial and refined potency metrics

Originally posted by MelbourneBoy: ↑

If you look at this situation from both a scientific & commercial perspective, a fundamental question of the FDA is this:

Can you prove that every patient gets a uniform dose and that the dose is equally effective?

Now from one side you could say that if 70% of patients live when only 15% did previously, does it matter? More people (kids in this case) when there is no real alternative.

However, consider this:

What if the 30% who died did so because the dose was not as effective as it was meant to be?
Some patients would then have had a reduced chance of survival and them, their families or their insurers have paid for a treatment that was less effective than it otherwise may have been.

This is a pretty big question and central to the work Mesoblast now needs to do.

They either need to show the FDA how their methods of uniformity and dose are appropriate, or find a way to modify their methods to better reflect FDA custom and practise.

Note: I am a holder, I am very supportive of the company, but I am also a TGA license holder here in Australia, so do have some insight into how these regulators work.

Good luck to everyone. Lets hope updates aren't too far away.

Expand

bingo. Pay attention to this guy

MSB Price at posting: $3.37 Sentiment: Hold Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

CRI

Critica unveils fresh REE hits near Jupiter play in WA – and 5 new prospects

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

NSM

North Stawell Minerals set to raise $1.3M in capital raising for exploration in Victoria

THB

Thunderbird picks up plethora of uranium targets based on EM survey in Canada

SGR

Thousands eye Star on HotCopper, SkyCity in strife – are ASX casino stocks safe anymore?

There are more pages in this discussion • 988 more messages in this thread...

First 30 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.48		Change 0.105(7.64%)		Mkt cap ! $1.689B

Open	High	Low	Value	Volume
$1.40	$1.49	$1.38	$8.181M	5.685M

Buyers (Bids)

No.	Vol.	Price($)
2	25443	$1.46

Sellers (Offers)

Price($)	Vol.	No.
$1.48	60811	4

View Market Depth

No.	Vol.	Price($)
2	25443	1.460
9	126101	1.455
2	19977	1.450
2	47643	1.445
1	18977	1.440

Price($)	Vol.	No.
1.480	60811	4
1.485	70703	4
1.490	209218	9
1.495	312041	9
1.500	528708	27

Last trade - 16.10pm 17/10/2024 (20 minute delay)

MSB (ASX) Chart

MSB to dispute FDA finding in Type A meeting, page-30

Critica unveils fresh REE hits near Jupiter play in WA – and 5 new prospects

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

North Stawell Minerals set to raise $1.3M in capital raising for exploration in Victoria

Thunderbird picks up plethora of uranium targets based on EM survey in Canada

Thousands eye Star on HotCopper, SkyCity in strife – are ASX casino stocks safe anymore?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

MSB to dispute FDA finding in Type A meeting, page-30

Top Stories

Critica unveils fresh REE hits near Jupiter play in WA – and 5 new prospects

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

North Stawell Minerals set to raise $1.3M in capital raising for exploration in Victoria

Thunderbird picks up plethora of uranium targets based on EM survey in Canada

Thousands eye Star on HotCopper, SkyCity in strife – are ASX casino stocks safe anymore?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News